LITTLE FALLS, N.J.--(BUSINESS WIRE)--CANTEL MEDICAL CORP. (NYSE:CMN) reported income from continuing operations of $2,157,000, or $0.13 per diluted share (inclusive of approximately $0.02 of stock-based compensation expense), on an 18% increase in sales to $60,910,000 for the second quarter ended January 31, 2008. This compares with income from continuing operations of $2,252,000, or $0.14 per diluted share (inclusive of approximately $0.01 of stock-based compensation expense), on sales of $51,635,000 for the second quarter ended January 31, 2007. For the six months ended January 31, 2008, the Company reported income from continuing operations of $4,096,000, or $0.25 per diluted share (inclusive of $0.04 of stock-based compensation expense), on an 18% increase in sales to $120,915,000. This compares with income from continuing operations of $3,975,000, or $0.25 per diluted share (inclusive of $0.02 of stock-based compensation expense), on sales of $102,119,000 for the six months ended January 31, 2007.
